VMAT2 and Parkinson’s disease: harnessing the dopamine vesicle

Por Lohr, Kelly M, Miller, Gary W
Publicado no Expert Rev Neurother (2014)

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease

Por Lohr, Kelly M., Masoud, Shababa T., Salahpour, Ali, Miller, Gary W.
Publicado no Eur J Neurosci (2016)

Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity

Por Lohr, Kelly M., Stout, Kristen A., Dunn, Amy R., Wang, Minzheng, Salahpour, Ali, Guillot, Thomas S., Miller, Gary W.
Publicado no ACS Chem Neurosci (2015)

Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice

Por Stout, Kristen A., Dunn, Amy R., Lohr, Kelly M., Alter, Shawn P., Cliburn, Rachel A., Guillot, Thomas S., Miller, Gary W.
Publicado no ACS Chem Neurosci (2016)

Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice

Por Coughlan, Christina, Walker, Douglas I., Lohr, Kelly M., Richardson, Jason R., Saba, Laura M., Caudle, W. Michael, Fritz, Kristofer S., Roede, James R.
Publicado no Parkinsons Dis (2015)

Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration

Por Alter, Shawn P., Stout, Kristen A., Lohr, Kelly M., Taylor, Tonya N., Shepherd, Kennie R., Wang, Minzheng, Guillot, Thomas S., Miller, Gary W.
Publicado no Exp Neurol (2015)

Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals

Por Lohr, Kelly M., Chen, Merry, Hoffman, Carlie A., McDaniel, Miranda J., Stout, Kristen A., Dunn, Amy R., Wang, Minzheng, Bernstein, Alison I., Miller, Gary W.
Publicado no Toxicol Sci (2016)

Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic...

Por Liu, Guoxiang, Sgobio, Carmelo, Gu, Xinglong, Sun, Lixin, Lin, Xian, Yu, Jia, Parisiadou, Loukia, Xie, Chengsong, Sastry, Namratha, Ding, Jinhui, Lohr, Kelly M., Miller, Gary W., Mateo, Yolanda, Lovinger, David M., Cai, Huaibin
Publicado no Hum Mol Genet (2015)

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Por Dunn, Amy R., Stout, Kristen A., Ozawa, Minagi, Lohr, Kelly M., Hoffman, Carlie A., Bernstein, Alison I., Li, Yingjie, Wang, Minzheng, Sgobio, Carmelo, Sastry, Namratha, Cai, Huaibin, Caudle, W. Michael, Miller, Gary W.
Publicado no Proc Natl Acad Sci U S A (2017)

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

Por Lohr, Kelly M., Bernstein, Alison I., Stout, Kristen A., Dunn, Amy R., Lazo, Carlos R., Alter, Shawn P., Wang, Minzheng, Li, Yingjie, Fan, Xueliang, Hess, Ellen J., Yi, Hong, Vecchio, Laura M., Goldstein, David S., Guillot, Thomas S., Salahpour, Ali, Miller, Gary W.
Publicado em 2014